Suppr超能文献

乳腺癌中的复发性和功能性调控突变。

Recurrent and functional regulatory mutations in breast cancer.

作者信息

Rheinbay Esther, Parasuraman Prasanna, Grimsby Jonna, Tiao Grace, Engreitz Jesse M, Kim Jaegil, Lawrence Michael S, Taylor-Weiner Amaro, Rodriguez-Cuevas Sergio, Rosenberg Mara, Hess Julian, Stewart Chip, Maruvka Yosef E, Stojanov Petar, Cortes Maria L, Seepo Sara, Cibulskis Carrie, Tracy Adam, Pugh Trevor J, Lee Jesse, Zheng Zongli, Ellisen Leif W, Iafrate A John, Boehm Jesse S, Gabriel Stacey B, Meyerson Matthew, Golub Todd R, Baselga Jose, Hidalgo-Miranda Alfredo, Shioda Toshi, Bernards Andre, Lander Eric S, Getz Gad

机构信息

The Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02124, USA.

Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts 02129, USA.

出版信息

Nature. 2017 Jul 6;547(7661):55-60. doi: 10.1038/nature22992. Epub 2017 Jun 28.

Abstract

Genomic analysis of tumours has led to the identification of hundreds of cancer genes on the basis of the presence of mutations in protein-coding regions. By contrast, much less is known about cancer-causing mutations in non-coding regions. Here we perform deep sequencing in 360 primary breast cancers and develop computational methods to identify significantly mutated promoters. Clear signals are found in the promoters of three genes. FOXA1, a known driver of hormone-receptor positive breast cancer, harbours a mutational hotspot in its promoter leading to overexpression through increased E2F binding. RMRP and NEAT1, two non-coding RNA genes, carry mutations that affect protein binding to their promoters and alter expression levels. Our study shows that promoter regions harbour recurrent mutations in cancer with functional consequences and that the mutations occur at similar frequencies as in coding regions. Power analyses indicate that more such regions remain to be discovered through deep sequencing of adequately sized cohorts of patients.

摘要

肿瘤的基因组分析已基于蛋白质编码区域中的突变鉴定出数百个癌症基因。相比之下,对于非编码区域中导致癌症的突变了解要少得多。在此,我们对360例原发性乳腺癌进行了深度测序,并开发了计算方法来识别显著突变的启动子。在三个基因的启动子中发现了明确的信号。FOXA1是激素受体阳性乳腺癌的已知驱动因子,其启动子中有一个突变热点,通过增加E2F结合导致过表达。RMRP和NEAT1这两个非编码RNA基因携带的突变会影响蛋白质与它们启动子的结合并改变表达水平。我们的研究表明,启动子区域在癌症中存在反复发生的具有功能后果的突变,且这些突变发生的频率与编码区域相似。功效分析表明,通过对足够规模的患者队列进行深度测序,还有更多这样的区域有待发现。

相似文献

1
Recurrent and functional regulatory mutations in breast cancer.乳腺癌中的复发性和功能性调控突变。
Nature. 2017 Jul 6;547(7661):55-60. doi: 10.1038/nature22992. Epub 2017 Jun 28.

引用本文的文献

9
REThinking the role of the RET oncogene in breast cancer.重新审视RET原癌基因在乳腺癌中的作用。
Front Oncol. 2024 Aug 1;14:1427228. doi: 10.3389/fonc.2024.1427228. eCollection 2024.

本文引用的文献

9
Comprehensive assessment of cancer missense mutation clustering in protein structures.蛋白质结构中癌症错义突变聚类的综合评估。
Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):E5486-95. doi: 10.1073/pnas.1516373112. Epub 2015 Sep 21.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验